6 completed. 6 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 6 |
| Phase 1 | 2 | Completed 2 |
Follow Nose Neoplasms: new trials by email Literature Review of Nose Neoplasms trials Research Report on Nose Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON). Bintrafusp alfa/M7824, Ibuprofen, PET scan - Olfactory Neuroblastoma, Esthesioneuroblastoma | Phase 2 | Completed | National Cancer Institute (NCI) | 11 | 2022-06-21 | 2025-08-08 |
| A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal Passages Cisplatin, Adjuvant Proton Radiotherapy, Endoscopic Resection - Paranasal Sinus Cancer, Nasal Cavity Tumor | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 3 | 2017-09-01 | 2025-05-16 |
| Adaptive Radiotherapy for Head and Neck Cancer Adaptive Radiotherapy - Head and Neck Cancer, Paranasal Sinus Cancer | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 64 | 2017-03-15 | 2021-10-26 |
| Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. placebo, laboratory biomarker analysis, questionnaire administration - Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Salivary Gland Squamous Cell Carcinoma | Phase 1 / Phase 2 | Completed | Ohio State University Comprehensive Cancer Center | 70 | 2007-09-04 | 2020-02-20 |
| Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer erlotinib + celecoxib - Cancer of the Pharynx, Cancer of the Larynx | Phase 1 / Phase 2 | Completed | Johnny Kao | 15 | 2007-02-01 | 2017-04-10 |
| Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer Cetuximab, Hydroxyurea, Fluorouracil - Head and Neck Cancer, Cancer of the Pharynx | Phase 2 | Completed | Johnny Kao | 33 | 2007-02-01 | 2018-03-13 |
Paranasal Sinus Neoplasms (5) · Laryngeal Neoplasms (4) · Head and Neck Neoplasms (3) · Esthesioneuroblastoma, Olfactory (2) · Hypopharyngeal Neoplasms (2) · Mouth Neoplasms (2) · Nasopharyngeal Neoplasms (2) · Oropharyngeal Neoplasms (2) · Pharyngeal Neoplasms (2) · Adenocarcinoma (1) · Carcinoma, Adenoid Cystic (1) · Carcinoma, Squamous Cell (1) · Salivary Gland Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
Neoplasms (6) · Neoplasms by Site (6) · Nose Diseases (6) · Otorhinolaryngologic Diseases (6) · Otorhinolaryngologic Neoplasms (6) · Respiratory Tract Diseases (6) · Respiratory Tract Neoplasms (6) · Paranasal Sinus Diseases (5) · Laryngeal Diseases (4) · Pharyngeal Diseases (4) · Stomatognathic Diseases (4) · Head and Neck Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Glandular and Epithelial (3)
Celecoxib (1) · Cetuximab (1) · Chemoprevention (1) · Cisplatin (1) · Electrocardiography (1) · Endoscopic Mucosal Resection (1) · Erlotinib Hydrochloride (1) · Etoposide (1) · Fluorouracil (1) · Hydroxyurea (1) · Ibuprofen (1) · Positron-Emission Tomography (1) · Radionuclide Imaging (1) · Radiotherapy (1) · Tomography, X-Ray Computed (1)
Johnny Kao (2) · Memorial Sloan Kettering Cancer Center (2) · National Cancer Institute (NCI) (1) · Ohio State University Comprehensive Cancer Center (1)
United States (6)
Amit Agrawal (1) · C. Jillian Tsai, MD (1) · Charalampos Floudas, M.D. (1) · Johnny Kao, M.D. (1) · Johnny Kao, MD (1) · Marc Cohen, MD (1)